For the glucose tolerance tests (GTT) and insulin tolerance tests (ITT), we observed that mice treated with IR-61 concurrently with a HFD or after obesity establishment had improved both glucose tolerance and insulin tolerance, which revealed that IR-61 treatment significantly improved insulin sensitivity in the obese mice (Fig. 6g, h). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.